ESCC ranks as the tenth most prevalent cancer in the world, with marked regional variation and a particularly high incidence in certain regions of China. Previous molecular epidemiological studies using a candidate gene approach have implicated a set of genetic varia tions that confer susceptibility to ESCC, primarily variations that are related to alcohol metabolism [1] [2] [3] [4] [5] [6] . The GWAS has emerged as a power ful and successful tool to identify common disease alleles by using highthroughput genotyping technology to interrogate a large number of tagging SNPs that serve as surrogates for untested common SNPs across the genome. In studies published thus far, GWAS of cancers of the upper aerodigestive tract, including ESCC in individuals of European 7, 8 and Japanese ancestry 9 , have shown that variants in ADH genes and/or ALDH2 are associated with risk of ESCC; in addition, these studies have shown an interaction for these loci with alcohol. Two GWAS showed that variants in PLCE1 are associated with risk of ESCC in Chinese populations 10,11 .
ESCC ranks as the tenth most prevalent cancer in the world, with marked regional variation and a particularly high incidence in certain regions of China. Previous molecular epidemiological studies using a candidate gene approach have implicated a set of genetic varia tions that confer susceptibility to ESCC, primarily variations that are related to alcohol metabolism [1] [2] [3] [4] [5] [6] . The GWAS has emerged as a power ful and successful tool to identify common disease alleles by using highthroughput genotyping technology to interrogate a large number of tagging SNPs that serve as surrogates for untested common SNPs across the genome. In studies published thus far, GWAS of cancers of the upper aerodigestive tract, including ESCC in individuals of European 7, 8 and Japanese ancestry 9 , have shown that variants in ADH genes and/or ALDH2 are associated with risk of ESCC; in addition, these studies have shown an interaction for these loci with alcohol. Two GWAS showed that variants in PLCE1 are associated with risk of ESCC in Chinese populations 10, 11 .
We recently reported a multistage GWAS of ESCC that was based on genotyping 666,141 SNPs in 2,031 cases and 2,044 controls with a second replication stage in 6,276 cases and 6,165 controls and identi fied three new loci that are associated with susceptibility to ESCC 12 . In this previous study, we attempted to replicate 29 SNPs with P ≤ 10 −7 . Because of our use of this stringent P value threshold, it is possible that some true ESCCassociated loci with moderate effect sizes were overlooked 13 . However, such loci may be detected by dense genotyp ing or analyzing larger sample sizes 14 . Furthermore, in our published GWAS report, we observed that three variants at 12q24 conferred ESCC risk through a genelifestyle interaction, with a pronounced ele vation of risk among alcohol users 12 . Alcohol intake is an important risk factor that contributes to the development of ESCC in Asian and other populations 15 . These findings underscore the fact that ESCC is a complex disease and that its etiology is related to environmental exposures, multiple genetic loci and geneenvironment interactions.
A r t i c l e s
Because some ESCC susceptibility loci act in an environment responsive manner, true associations might not be detected by GWAS without accounting for environmental risk factors 16 . Thus, to discover these susceptibility loci, incorporation of environmental risk factors in the context of GWAS may yield additional regions that are worthy of followup studies.
Here we report a new, multistage GWAS of ESCC in a total of 10,123 cases with ESCC and 10,664 controls ( Table 1) . We also report, to our knowledge, the first genomewide geneenvironment interaction analysis of ESCC that incorporates alcohol drinking. We replicated results from these GWAS in an additional casecontrol panel from a highrisk population.
RESULTS

New loci associated with susceptibility to ESCC
To identify new susceptibility loci for ESCC, we analyzed 169 promis ing SNPs (with 10 −7 < P < 10 −4 in our previous GWAS; Supplementary Table 1) in replication 1 comprising 3,571 cases and 3,602 controls. We further verified the 18 SNPs with P < 0.01 in replication 2 com prising 4,521 cases and 5,018 controls. We found that 15 SNPs were significantly associated with ESCC risk in the replication 2 samples in the same direction as in the genomewide scan and replication 1 (P = 2.20 × 10 −3 to P = 1.67 × 10 −24 ). A joint analysis of the genome wide scan data together with the samples from replications 1 and 2
showed that these 15 associations reached genomewide significance (all P ≤ 2.49 × 10 −11 ; Tables 2 and 3) .
Eight of the significant makers were located at chromosome 4q23, which harbors a cluster of seven alcohol dehydrogenase superfamily genes (ADH genes). The top marker in this region was rs1042026 (odds ratio (OR) = 1.35, 95% CI 1.29-1.41, P combined = 1.78 × 10 −39 ), and the other seven SNPs in this region are in moderate linkage disequilibrium (LD) with rs1042026 (r 2 = 0.30-0.49), all of which provided significant marginal associations in the combined dataset (P combined = 1.26 × 10 −29 to P combined = 2.75 × 10 −20 ) (Fig. 1a) . After conditioning on rs1042026, the association P values for the other seven SNPs increased by over 13 orders of magnitude, suggesting that the association signals of these other seven SNPs probably point toward the same locus, which is marked by the top SNP (rs1042026) (Supplementary Table 2 ). An imputation analysis in the initial GWAS identified associations for 111 SNPs within a 2Mb region centered on rs1042026 (P ≤ 10 −4 ), but none of these SNPs was more significant than the index marker, rs1042026, and a conditional analysis did not provide evidence for a second, independent susceptibility allele in this region (Supplementary Table 3 ).
The markers rs4785204 and rs7206735 at 16q12.1 were also strong signals that were associated with ESSC risk (OR = 1.24, 95% CI 1.18-1.29, P combined = 2.24 × 10 −20 for rs4785204 and OR = 1.20, 95% CI 1.15-1.26, P combined = 1.97 × 10 −16 for rs7206735; Fig. 1b) . The P values shown are two sided and were calculated by the additive model in a logistic regression analysis with age, sex, smoking, drinking and the first three principal components (for the GWAS stage only) as covariates. a Discovered by imputation analysis. Chr., chromosome; MAF, minor allele frequency in controls; OR, odds ratio for the minor allele. The P values shown are two sided and were calculated by an additive model in a logistic regression analysis with age, sex, smoking, drinking and the first three principal components (for the GWAS stage only) as covariates for the subgroups of case_control (individuals included in the case-control study), nondrinker and drinker. The P values for the gene × environment interaction were calculated by conducting a 1-degree-of-freedom Wald test of a single interaction parameter (SNP × drinking status) as implemented in an unconditional logistic regression with age, sex, smoking as covariates. MAF, minor allele frequency in the controls; OR, odds ratio for the minor allele; G × E, gene × environment interaction.
These two SNPs are located in close proximity to each other and are in moderate LD (r 2 = 0.41 in controls); after conditioning on rs4785204, rs7206735 was no longer genomewide significant (Supplementary Table 2 ). An imputation analysis identified 40 untyped SNPs cluster ing in two blocks with high LD tagged by these markers that reached a significance of P ≤ 10 −4 ; again, after conditioning on the index SNP (rs4785204), there was little evidence of a second susceptibility allele in this region (Supplementary Table 3) .
We found a new susceptibility locus, rs2239815, at 22q12 (OR = 1.18, 95% CI 1.13-1.23, P combined = 3.88 × 10 −15 ). However, of the 36 imputed SNPs with P ≤ 10 −4 in the region tagged by rs2239815, 8 comprised a separate significant block that was only in weak LD with rs2239815 (r 2 = 0.21-0.39) (Fig. 1c) . We selected the top two imputed SNPs from this block, rs4822983 and rs1033667, both of which had P values that were smaller than that of the genotyped index SNP, rs2239815, in the initial GWAS for further replication in all samples. We found that each of these two SNPs was significantly associated with ESCC risk (OR = 1.27, 95% CI 1.21-1.34, P combined = 1.94 × 10 −22 for rs4822983 and OR = 1.25, 95% CI 1.19-1.30, P combined = 4.85 × 10 −22 for rs1033667; Table 2 ). After conditioning on rs4822983 in the combined sample, evidence for the associations between rs2239815 and rs1033667 and ESCC dropped by over ten orders of magnitude (Supplementary Table 2) ; similarly, after con ditioning on rs4822983 in the initial GWAS, there was little evidence of a second susceptibility marker among the imputed SNPs in this region (Supplementary Table 3) .
The SNP rs2239612 at 3q27 was also associated with ESCC risk (OR = 1.21, 95% CI 1.15-1.27, P combined = 5.74 × 10 −14 ), all seven imputed SNPs in this region were in strong LD with rs2239612 (r 2 = 0.94-0.99), and we identified no other significant LD block in this region (Fig. 1d  and Supplementary Table 3 ).
Risk lock found by genome-wide gene-environment analysis
We performed a genomewide geneenvironment interaction anal ysis using previous genomewide-association scan data by testing whether the perallele odds ratio for each SNP differed between ever drinkers and never drinkers. A quantilequantile plot of the observed versus expected Wald χ 2 1degreeoffreedom test for inter action showed no evidence for inflation (λ = 1.004; Supplementary  Fig. 1a ). There were 25 promising SNPs associated with ESCC risk at significance levels ranging from P G × E = 1.42 × 10 −23 to P G × E = 9.88 × 10 −5 (Supplementary Fig. 1b) . Among them, 15 SNPs were located at 12q24, including rs11066015 (P G × E = 1.42 × 10 −23 ), rs11066280 (P G × E = 1.25 × 10 −17 ) and rs2074356 (P G × E = 3.38 × 10 −16 ), which our previous report showed all interact with alcohol drinking to promote ESCC risk 12 . rs11066015 is in strong LD with rs671 (r 2 = 0.79), a functional SNP in ALDH2 (encoding aldehyde dehydrogenase2) that is known to be associated with both a flushing response to alcohol intake and ESCC risk in a drinkingbehaviorspecific manner 4, [7] [8] [9] . We then performed a fasttrack replication in the replication 1 samples of the ten remaining tag SNPs located in regions other than 12q24. Of these ten SNPs, eight did not replicate (all P G × E > 0.05; Supplementary Table 4), and we did not evaluate them further. Additional replication (replication 2) of rs9288520 at 2q22 and rs17450420 at 13q33 verified their associations with ESCC risk (combinedsample P G × E = 4.39 × 10 −11 and P G × E = 4.80 × 10 −8 , respectively). The minor allele of rs9288520 was associated with reduced risk of ESCC in all nondrinkers (OR = 0.81, 95% CI 0.77-0.86, P = 4.72 × 10 −12 ) but was associated with increased risk in all drinkers (OR = 1.09, 95% CI 1.02-1.16, P = 0.01). Similarly, the minor allele of rs17450420 was associated with reduced ESCC risk in nondrinkers (OR = 0.78, 95% CI 0.68-0.89, P = 0.0002) but with increased risk in drinkers (OR = 1.34, 95% CI 1.16-1.54, P = 4.65 × 10 −5 ; Table 4 ). Neither of these two SNPs was significantly related to drinking status in cases, controls or the combined sample (data not shown). To increase the spectrum of variants tested, we performed an imputation analysis in the GWAS set and identified two and nine imputed SNPs, respectively, in the two regions that showed significant interactions with drinking (P G × E < 10 −4 ); however, none of these SNPs was more significantly A r t i c l e s related to cancer than the index markers in each region, rs17450420 and rs9288520 (Fig. 1e,f) .
Alcohol use and interaction in ESCC susceptibility
Stratified analyses showed that the newly associated SNPs at 22q12, 16q12.1 and 3q27 were all significantly associated with ESCC risk in the same direction in both drinkers and nondrinkers; the asso ciations did not differ significantly between subgroups categorized by alcoholdrinking status (Supplementary Table 5 ). The asso ciations for the eight SNPs (rs1042026, rs3805322, rs17028973, rs1614972, rs17033, rs1229977, rs1789903 and rs1893883) at 4q23 differed by alcohol use, with higher risk in drinkers than in non drinkers (interaction P = 2.54 × 10 −7 to P = 3.23 × 10 −2 ; Table 3) , which is consistent with previously published epidemiologic data 4, 7, 9, 15, 17 . An analysis of the joint effects of drinking, rs1042026 in ADH1B and rs11066015 in ALDH2 on risk of developing ESCC iden tified that the odds in drinkers carrying risk alleles at both ADH1B (GA or AA genotype) and ALDH2 (GA or AA genotype) was approxi mately fourfold higher than that in drinkers carrying the nonrisk ADH1B G and ALDH2 G alleles and was more than threefold higher than that in nondrinkers carrying the risk alleles. The effect sizes of the ADH1B and ALDH2 variants for ESCC risk in nondrinkers were not large ( Fig. 2 and Supplementary Table 6 ).
Replication of susceptibility loci in a high-risk population
We next examined whether these significant loci were also associated with susceptibility to ESCC in 1,410 cases and 1,656 controls obtained from a highrisk population in Shanxi province, China, as described in a previous GWAS 11 . We found that among the SNPs listed in Tables  2-4 , 4 showed significant association (Supplementary Table 7 ) in this independent dataset. rs2239815 (OR = 1.24, 95% CI 1.12-1.38, P = 3.23 × 10 −5 ), rs4822983 (OR = 1.28, 95% CI 1.07-1.54, P = 0.0082) and rs1033667 (OR = 1.35, 95% CI 1.20-1.51, P = 2.95 × 10 −7 ) at 22q12 and rs2239612 (OR = 1.15, 95% CI 1.01-1.30, P = 0.0343) at 3q27 were all associated with increased ESCC risk in this group, as was observed in the other groups. A genedrinking interaction analysis showed that rs1614972 in ADH1C at 4q23 had evidence for replication (OR = 1.37, 95% CI 1.03-1.82, P G × E = 0.0281).
DISCUSSION
In a multistage GWAS, we identified new susceptibility loci associated with ESCC risk across three independent study groups comprising a total of 10,123 cases and 10,664 controls. Among these loci, three had a significant interaction with alcohol drinking, an important lifestyle risk factor in the development of ESCC. We also confirmed some of our findings in an independent study from a highrisk population. To the best of our knowledge, this is one of the largest studies to explore geneenvironment interactions for risk of developing ESCC by incorporating alcoholdrinking status into the primary GWAS stage 1 analysis.
Among the regions with a notable marginal effect for risk of ESCC, two at 16q12.1 tagged by rs4785204 and rs7206735 contain the TMEM188, HEATR3 and PAPD5 genes, which are interesting and plausible candidate genes worthy of followup studies.
In a further imputation analysis, we identified two LD blocks at 22q12 that contain XBP1 and CHEK2, which encode Xbox binding protein 1 and a cellcycle checkpoint kinase, respectively. XBP1 is an important part of the unfolded protein response that is involved in the regulation of endoplasmic reticulum stress-mediated apoptosis, and aberrant expression of XBP1 has been implicated in cancer development and progression, as well as in resistance to drugs [18] [19] [20] [21] . The P values shown are two sided and were calculated by an additive model in a logistic regression analysis with age, sex, smoking, drinking and the first three principal components (for the GWAS stage only) as covariates for the subgroups of nondrinker and drinker. P values for the gene × environment interaction were calculated by conducting a 1-degree-of-freedom Wald test of a single interaction parameter (SNP × drinking status) as implemented in an unconditional logistic regression with age, sex, smoking as covariates. MAF, minor allele frequency in the controls; OR, odds ratio for the minor allele; chr., chromosome; G × E, gene × environment interaction.
A r t i c l e s CHEK2 is responsible for preventing DNAdamaged cells from enter ing into mitosis, a crucial step to avert cancer development. It has therefore been considered as a candidate cancer susceptibility gene 22 . Markers near CHEK2 have been found previously to be promising signals in the NCI GWAS 11 that we used for replication in this study. In view of the probable important roles of XBP1 and CHEK2 in cancer, it is plausible that genetic variations influencing the functions of these genes may confer susceptibility to ESCC.
rs2239612 is located at 3q27 in ST6GAL1, which encodes ST6 βgalactosamide α2,6sialyltransferase. Previous studies have shown that ST6GAL1 is upregulated in many types of human cancers, and elevated expression of ST6GAL1 is also correlated with tumor inva siveness and metastasis [23] [24] [25] [26] .
In this study, we performed geneenvironment interaction analyses by testing for differences in the perallele odds ratios between ever drinkers and never drinkers. These analyses identified three genomic regions that had significant interactions with alcohol consumption to promote risk of developing ESCC. Notably, on chromosome 4q23 there is a region that harbors a cluster of seven genes encoding alco hol dehydrogenase (ADH) family proteins ((listed 5′ to 3′) ADH7, ADH1C, ADH1B, ADH1A, ADH6, ADH4 and ADH5). ADHs oxidize alcohol to acetaldehyde, a carcinogen that is probably important in the etiology of alcoholrelated cancers 27 . Drinkers with the fast ADH metabolizer genotype produce more acetaldehyde and are expected to have an elevated risk of these cancers. However, in this study, we were unable to determine the exact contribution of individual variants because of the LD pattern over the region covering the ADH genes. Deep sequencing of this region is warranted to map candidate genes and variants for followup functional analyses. Using a genomewide geneenvironment interaction analysis, we found that the most signi ficant interaction region was for variants at 12q24 harboring ALDH2, which encodes aldehyde dehydrogenase2 that, in turn, detoxifies acetaldehyde to acetate. The directions of our associations reported here are consistent with those reported in our previous GWAS 12 and other published studies 4, 8, 9 . Furthermore, in the present study, we evaluated the joint effects of ADH1B and ALDH2 variants and drink ing on ESCC risk and found that individuals who carried both of the risk alleles of ADH1B and ALDH2 and were classified as alcohol drinkers had the highest risk. These findings clearly indicate a gene environment interaction between alcohol use and genetic variation in the alcoholmetabolizing pathway for developing ESCC. Because ADHs oxidize alcohol to carcinogenic acetaldehyde, which is then detoxified by aldehyde dehydrogenases, it is anticipated that indi viduals with the combination of the fast alcohol metabolizer geno type and the slow acetaldehyde metabolizer genotype would be most susceptible to ESCC. These results strongly highlight the potential importance of reducing alcohol use in individuals carrying highrisk alleles to reduce ESCC risk.
We also identified associations with ESCC risk for rs9288520, located upstream of IGFBP2 at 2q22, and rs17450420, located in a gene desert upstream of SLC10A2 at 13q33. These two variants did not show marginal effects but were significantly associated with risk when alcohol drinking was incorporated into the genomewide gene environment interaction analysis. Compared to common alleles, the minor alleles of these two SNPs were associated with decreased risk of ESCC in nondrinkers and increased risk in drinkers. IGFBP2 produces insulinlike growth factor binding protein 2, which is involved in cell proliferation, migration and apoptosis, and elevated serum IGFBP2 concentrations have been detected in patients with various types of cancer 28 . Interestingly, it has been shown that IGFBP2 RNA is overexpressed in the placenta and fetal lungs of rats fed with alcohol, and this overexpression is associated with ethanolinduced growth retardation 29 . SLC10A2 encodes a sodium/bile acid cotransporter and has been suggested to be associated with alcohol dependence 30 .
Because of the stringent P values we required for statistical signifi cance to prevent falsepositive findings in the GWAS, additional asso ciations with promising P values were not confirmed in the present study, underscoring the need to continue the search for new loci 13 . Therefore, it is important to undertake complementary strategies to discover additional variants, particularly when some genetic effects are dependent on environmental exposure and may show a substan tial effect only when a specific environmental exposure is present. Indeed, by replication of more potential associated SNPs in expanded samples and by performing a genomewide geneenvironment inter action analysis, we extended our GWAS results with the discovery of nine new ESCC susceptibility loci.
We also replicated the results in an additional casecontrol group from Shanxi province, a region with extremely high rates of ESCC in China 11 . We verified that four of the nine loci identified in the GWAS and replication samples also had significant marginal genetic effects on ESCC risk in this highrisk population; however, we found only modest evidence for a gene-alcohol drinking interaction in this popu lation. This apparent inconsistency probably reflects differences in environmental exposures between general and highrisk populations. It is well known that in general populations, alcohol drinking and tobacco smoking are the major risk factors for ESCC 15, 17 . However, in some highrisk regions of the Shanxi and Henan provinces in China, alcohol drinking has little or no association with ESCC risk 31, 32 , whereas other factors such as nutritional deficiencies, family history and certain chemical carcinogens in the diet are strongly associated with this type of cancer [33] [34] [35] . In this context, it is therefore not surprising to observe different genetic risks between general and highrisk populations. These differences also emphasize the impor tance of further analyses of interactions between genetic variants and the specific environmental factors in highrisk populations.
In conclusion, we have identified new susceptibility loci for ESCC in Chinese populations, extending our previous findings and advancing the understanding of the genetic etiology of ESCC. The newly identi fied susceptibility loci warrant followup finemapping and functional studies. Furthermore, the risk variants in the alcohol metabolism pathway that we have confirmed in this large study might be useful for identifying highrisk individuals for the prevention of ESCC in the Chinese population, particularly where alcohol consumption is a possible health risk.
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